Trial Information

Summary: A study of the use of donepezil hydrochloride (Aricept ) in 10 to 17 year olds with Down Syndrome (Trisomy 21)

A study of the use of donepezil hydrochloride (Aricept ) in 10 to 17 year olds with Down Syndrome (Trisomy 21)

Study Inclusion / Exclusion Criteria:
  • Trisomy 21 Down Syndrome, mild to moderate congnitive dysfunction
  • Between the ages of 10 and 17
  • Residing in the community with a caregiver
  • Have no unstable health conditions
  • Be able to submit to blood tests
  • The child should be verbal
  • On stable doses of medications

    • Contact:

    Mary Sergalis LPN
    Laszlo J Mate MD
    927 45th St., Ste. 105
    West Palm Beach, FL 33407
    Telephone: 561-882-0088
    Fax: 561-842-4983
    Email:

    If you would like to learn more about participating in this study, please send an e-mail message using the form below.

    *Subject:

    Name:

    Address:

    City:

    State:

    *Zip:

    *Country:

    Phone:

    *Email address:

    Message:

    Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

    This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

    Trial listings updated: June 1, 2008 at 6:42:54 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA